ENHANCEMENT BY 5-HYDROXYTRYPTAMINE AND ANALOGS OF DESENSITIZATION OF NEURONAL AND MUSCLE NICOTINIC RECEPTORS EXPRESSED IN XENOPUS OOCYTES

被引:19
|
作者
CROSS, KML
FOREMAN, RC
CHAD, JE
机构
基金
英国惠康基金;
关键词
DESENSITIZATION; NICOTINIC ACETYLCHOLINE RECEPTORS; KETANSERIN; 5-HYDROXYTRYPTAMINE; XENOPUS OOCYTES;
D O I
10.1111/j.1476-5381.1995.tb14951.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The action of 5-hydroxytryptamine (5-HT) on neuronal and muscle nicotinic acetylcholine receptors (nicotinic AChR) expressed in Xenopus oocytes was studied. 2 5-HT enhanced the rate of desensitization of the acetylcholine (ACh) current response in all receptor subtypes investigated (muscle, alpha beta(2) gamma delta and alpha(4) beta(2)), acting in a dose-dependent manner. 3 5-HT also reduced the peak current elicited by ACh in a dose-dependent manner. The IC50 value for the muscle type receptor was 227 +/- 0.44 mu M, and 166 +/- 0.47 mu M and 283 +/- 0.28 mu M for the combinations alpha beta(2) gamma delta and alpha(4) beta(2) respectively. 4 The effect of 5-HT on the responses to ACh (10 mu M) was found to be independent of membrane voltage over the range tested (-80 to -10 mV), and to be readily reversed by washout. 5 The action of 5-HT could be mimicked by structurally similar molecules. The homologue tryptamine was less potent than 5-HT in blocking the ACh current, with an IC50 of 1.0 +/- 0.02 mM. Ketanserin, a 5-HT2 receptor antagonist, was more potent than 5-HT, the IC50 being 49.0 +/- 1.4 mu M. 6 We postulate that a highly conserved portion of the tertiary structure of nicotinic AChRs, which includes some part of the ACh binding site, has affinity for 5-HT and structural analogues.
引用
收藏
页码:1636 / 1640
页数:5
相关论文
共 26 条
  • [1] BLOCK BY 5-HYDROXYTRYPTAMINE OF NEURONAL ACETYLCHOLINE-RECEPTOR CHANNELS EXPRESSED IN XENOPUS OOCYTES
    NAKAZAWA, K
    AKIYAMA, T
    INOUE, K
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 1995, 15 (04) : 495 - 500
  • [2] Effects of benzothiazepines on human neuronal nicotinic receptors expressed in Xenopus oocytes
    Sala, F
    Mulet, J
    Valor, LM
    Criado, M
    Sala, S
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 136 (02) : 183 - 192
  • [3] DESENSITIZATION OF EMBRYONIC NICOTINIC ACETYLCHOLINE-RECEPTORS EXPRESSED IN XENOPUS OOCYTES
    BUFLER, J
    FRANKE, C
    WITZEMANN, V
    RUPPERSBERG, JP
    MERLITZE, S
    DUDEL, J
    NEUROSCIENCE LETTERS, 1993, 152 (1-2) : 77 - 80
  • [4] DESENSITIZATION OF JUNCTIONAL AND EXTRAJUNCTIONAL NICOTINIC ACH RECEPTORS EXPRESSED IN XENOPUS-OOCYTES
    MORALES, A
    SUMIKAWA, K
    MOLECULAR BRAIN RESEARCH, 1992, 16 (3-4): : 323 - 329
  • [5] NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTORS EXPRESSED IN XENOPUS OOCYTES - ROLE OF THE ALPHA SUBUNIT IN AGONIST SENSITIVITY AND DESENSITIZATION
    GROSS, A
    BALLIVET, M
    RUNGGER, D
    BERTRAND, D
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1991, 419 (05): : 545 - 551
  • [6] BLOCKAGE OF NICOTINIC ACETYLCHOLINE-RECEPTORS BY 5-HYDROXYTRYPTAMINE
    GRASSI, F
    POLENZANI, L
    MILEO, AM
    CARATSCH, CG
    EUSEBI, F
    MILEDI, R
    JOURNAL OF NEUROSCIENCE RESEARCH, 1993, 34 (05) : 562 - 570
  • [7] Block by 5-hydroxytryptamine and apomorphine of recombinant human neuronal nicotinic receptors
    Nakazawa, K
    Ohno, Y
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 374 (02) : 293 - 299
  • [8] SUBUNIT-DEPENDENT ACTION OF LEAD ON NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTORS EXPRESSED IN XENOPUS OOCYTES
    OORTGIESEN, M
    ZWART, R
    VANKLEEF, RGDM
    VIJVERBERG, HPM
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1995, 22 (05) : 364 - 365
  • [9] The tramadol metabolite, O-desmethyl tramadol, inhibits 5-hydroxytryptamine type 2C receptors expressed in Xenopus oocytes
    Horishita, Takafumi
    Minami, Kouichiro
    Uezono, Yasuhito
    Shiraishi, Munehiro
    Ogata, Junichi
    Okamoto, Takashi
    Shigematsu, Akio
    PHARMACOLOGY, 2006, 77 (02) : 93 - 99
  • [10] 5-Hydroxytryptamine directly inhibits neuronal nicotinic acetylcholine receptors in rat trigeminal ganglion neurons
    Hu, Wang-Ping
    Ma, Shi-Yu
    Wu, Ji-Liang
    Li, Zhi-Wang
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 574 (2-3) : 120 - 126